Hu Sheng-Shou
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Geriatr Cardiol. 2024 Aug 28;21(8):775-778. doi: 10.26599/1671-5411.2024.08.007.
The (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this eighth section of the report offers a comprehensive analysis of pulmonary embolism and deep venous thrombosis. In recent years, research in the field of pulmonary vessel in China has made great progress. A number of nationwide multi-center registry research results have filled the gaps in the epidemiology, diagnosis and treatment of pulmonary hypertension and venous thromboembolism. Different types of pulmonary hypertension still need attention to the identification of risk factors and/or risk stratification, and venous thromboembolism needs attention in the prevention and the overall management inside and outside hospital. In the future, we look forward to the publication of more high-quality research in China, which could be able to improve relevant guidelines for pulmonary vascular diseases both domestically and internationally.
《2022年中国心血管健康的复杂状况》。与上一节相关,本报告的第八节对肺栓塞和深静脉血栓形成进行了全面分析。近年来,中国肺血管领域的研究取得了很大进展。一些全国性多中心注册研究结果填补了肺动脉高压和静脉血栓栓塞症在流行病学、诊断和治疗方面的空白。不同类型的肺动脉高压仍需关注危险因素的识别和/或风险分层,静脉血栓栓塞症在预防以及院内和院外的整体管理方面都需要关注。未来,我们期待中国能发表更多高质量研究,从而能够在国内外改进肺血管疾病的相关指南。